- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips' Brilliance iCT boosts quality with new technology
Volume-rendered image processed from data acquired using the Philips 256-slice Brilliance iCT scanner at WellStar Kennestone Hospital in Marietta, GA, shows right iliac artery stenosis and multiple calcifications on left iliac artery. Bony landmarks are ghosted in background, the result of a new visualization technique introduced by Philips to assist in planning interventions. The Marietta installation boosts the number of Philips 256-slice CTs to nine. These sites, located at medical facilities around the world, have scanned more than 6000 patients, according to Philips Healthcare. With rotational speeds up to 0.27 seconds and a detector that spans 8 cm, the iCT supports applications in trauma, cardiac, interventional, pediatric, vascular, and bariatrics, as well as general imaging. Slotted anode and dual-support spiral groove bearing built into the scanner's x-ray tube enable 120- kW imaging and focal spot integrity at high rotational speeds. 'Smart' focal spot simultaneously deflects x-ray beam in x- and z-axes to acquire double the data during each rotation. (Provided by Philips)
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
